Topic Omics
proteomics
metabolomics
transcriptomics
etc.
Topic
All
Artificial Intelligence / Machine Learning
Bioinformatics Software
Bulk RNA-Seq
Cancer
Cloud
Data Management
Data Resources
Data Science
Flow Cytometry
Genomics
Image Analysis
Microbiome
NCI Genomic Data Commons
NIDAP
NIH High Performance Unix Cluster Biowulf
Omics
Pathway Analysis
Programming
Proteomics
Sequencing Technologies
Single Cell RNA SEQ
Single Cell Technologies
Spatial Transcriptomics
Statistics
Transcriptomics
Variant Analysis
Format
All
Class
Distinguished Speaker
Lecture
Seminar
Webinar
Workshop
Event Organizer
All
BTEP
BYOB
CBIIT
CCR Single Cell Analysis and Sequencing Facilities
CDSL
Data Science Seminar Series
Data Sharing and Reuse Seminar Series
Earl Stadtman Investigator Program
FNL Science and Technology Group
Frederick Faculty Seminar Series
HPC Biowulf
Laboratory of Cell Biology (LCB)
Molecular Discovery Seminar Series
NCI
NCI and the Society for Immunotherapy of Cancer (SITC)
NCI CCR Liver Cancer Program (LCP)
NCI Containers and Workflows Interest Group
NCI Data Science Learning Exchange
NCI Genomic Data Commons
NCI SS/SC
NHGRI
NHLBI
NHLBI Proteomics Core
NIA
NIA Artificial Intelligence Lecture Series
NIAID
NICHD
NIDA
NIDCR
NIH
NIH HPC
NIH Metabolomics Scientific Interest Group
NIH Office of Data Science Strategy (ODSS)
NIH STRIDES
NIH Training Library
NIH.AI
Office of Cancer Clinical Proteomics Research
Qlucore
Scientific Library at Frederick
Single Cell Users Group
Systems Biology Interest Group
The NIH Metabolomics Interest Group
Past & Future Events
All
Only Past Events
Only Future Events
may
Event Details
For our next CDSL webinar we will have a guest lecture by Dr. Julio Saez-Rodriguez from the Institute for Computational Biomedicine, Heidelberg. Bio: Julio Saez-Rodriguez is Professor of Medical Bioinformatics and Data Analysis at
more
Event Details
For our next CDSL webinar we will have a guest lecture by Dr. Julio Saez-Rodriguez from the Institute for Computational Biomedicine, Heidelberg.
Bio: Julio Saez-Rodriguez is Professor of Medical Bioinformatics and Data Analysis at the Faculty of Medicine of Heidelberg University, director of the Institute for Computational Biomedicine, group leader of the EMBL-Heidelberg University Molecular Medicine Partnership Unit and a co-director of the DREAM challenges. He holds a PhD (2007) in Chemical Engineering. He was a postdoctoral fellow at Harvard Medical School and M.I.T (2007- 2010), group leader at EMBL-EBI, Cambridge (2010-2015), and professor of Computational Biomedicine at RWTH Aachen (2015-2018). His research focuses on computational methods to understand and treat the deregulation of cellular networks in disease (www.saezlab.org).
Abstract: Multi-omics technologies, and in particular those with single-cell and spatial resolution, provide unique opportunities to study deregulation of intra- and inter-cellular processes in cancer and other diseases. In this talk I will present recent methods and applications from our group towards this aim, with a focus is on computational approaches that combine data with biological knowledge.
Meeting Link
Join ZoomGov MeetingTime
(Wednesday) 11:00 am - 12:00 pm
Location
Online
Organizer
CDSLNCI CCR Cancer Data Science LabArati Rajeevan, arati.rajeevan@nih.gov
Event Details
Metabolomic and multi-omic data are increasingly being collected in basic, preclinical, and clinical research studies. Interpretation of these data though remains challenging. Common challenges include the difficulty in identifying metabolites
more
Event Details
Metabolomic and multi-omic data are increasingly being collected in basic, preclinical, and clinical research studies. Interpretation of these data though remains challenging. Common challenges include the difficulty in identifying metabolites and assigning unique identifiers, and the scarcity of resources that provide up-to-data comprehensive annotations and analysis tools on integrated genes/proteins and metabolites. To aid in interpreting these complex data, we developed RaMP-DB 2.0, a public resource that contains comprehensive biological, structural/chemical, disease, and ontology annotations for human metabolites and metabolic genes/proteins. The associated RaMP-DB 2.0 framework provides the ability to query those annotations and to perform pathway and chemical enrichment analysis on input multi-omic datasets. Since our first release, RaMP-DB 2.0 has been substantially upgraded and now includes an expanded breadth and depth of functional and chemical annotations, and a reproducible and semi-automated method for entity resolution of analytes across the different source databases pulled. The usability of the RaMP-DB 2.0 has also been improved through updates of pathway and chemical enrichment analysis methods, and a completely revamped web interface and associated public API for programmatic access. RaMP-DB 2.0 currently pulls information from HMDB, KEGG (through HMDB), Reactome, WikiPathways, Lipid-MAPS, and ChEBI and includes 254,860 chemical structures, of which 43,338 are lipids, 15,389 genes, 53,745 pathways, 807,362 metabolic enzyme/metabolite reactions, and 699 functional ontologies (biofluid, health condition, etc.). RaMP-DB 2.0 is available at https://rampdb.nih.gov/.
Speaker:
Ewy Mathé, Ph.D., Director of Informatics, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, NIH
Register Here
RegisterTime
(Tuesday) 11:00 am - 12:00 pm
Location
Online
Organizer
The NIH Metabolomics Interest Group